ConductScience.org, home

Paper21847293

Successful treatment of obsessive-compulsive disorder with zimelidine, a serotonin re-uptake inhibitor.

Prasad A. Indian J Psychiatry, 1983. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Successful treatment of obsessive-compulsive disorder with zimelidine, a serotonin re-uptake inhibitor. Papers, record 21847293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21847293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Successful treatment of obsessive-compulsive disorder with zimelidine, a serotonin re-uptake inhibitor.
PubMed
Journal
Indian J Psychiatry
PubMed
Year
1983
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.12
iCite
Revised in PubMed
2021-10-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Prasad AA

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16159865Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.Arch Gen Psychiatry1980https://conductscience.org/library/papers/6159865PubMed
27270737Rapid response of severe obsessive-compulsive disorder to tranylcypromine.Am J Psychiatry1981https://conductscience.org/library/papers/7270737PubMed
35656266Complications of obsessional neurosis.Br J Psychiatry1968https://conductscience.org/library/papers/5656266PubMed
44716072Phenomenological aspects of obsessional patients treated with clomipramine.Br J Psychiatry1973https://conductscience.org/library/papers/4716072PubMed
55172935Chlorimipramine in obsessional states. (A pilot study).Psychosomatics1971https://conductscience.org/library/papers/5172935PubMed
66174553The psychopharmacological treatment of obsessive-compulsive disorder: a review.J Clin Psychopharmacol1981https://conductscience.org/library/papers/6174553PubMed
77400108Amitriptyline therapy of obsessive-compulsive neurosis.J Clin Psychiatry1980https://conductscience.org/library/papers/7400108PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
22988331Antidepressant-induced mania in obsessive compulsive disorder.Indian J Psychiatry2012https://conductscience.org/library/papers/22988331PubMed
21836704Research on antidepressants in India.Indian J Psychiatry2010https://conductscience.org/library/papers/21836704PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21847293

GET https://conductscience.org/api/papers/v1/21847293/authors